Corpus Intelligence IC Memo — HOSPITAL FOR BEHAVIORAL MEDICINE 2026-04-26 10:39 UTC
IC Memo — HOSPITAL FOR BEHAVIORAL MEDICINE
Investment Committee Memorandum | MA | 120 beds | Grade C | EBITDA uplift $2.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HOSPITAL FOR BEHAVIORAL MEDICINE

CCN 224045 | COLES, MA | 120 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HOSPITAL FOR BEHAVIORAL MEDICINE is a 120-bed suburban community hospital in COLES, MA with $28.7M in net patient revenue and a -12.3% operating margin. The hospital serves a payer mix of 14.2% Medicare, 1.5% Medicaid, and 84.3% commercial.

Thesis: Undervalued. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -12.3% to -4.9% (+736bps).

Net Revenue HCRIS$28.7M
Current EBITDA COMPUTED$-3.5M
Operating Margin COMPUTED-12.3%
Occupancy HCRIS62.6%
Revenue / Bed COMPUTED$240K
Net-to-Gross HCRIS68.5%
Distress Probability ML49.7%

2. Market Context & Competitive Position

99
MA Hospitals
-12.2%
State Median Margin
58
Comparable Hospitals

MA has 99 Medicare-certified hospitals with a median operating margin of -12.2%. The target's margin of -12.3% places it below the state median. Among 58 size-comparable peers (60-240 beds), the median margin is -10.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (60-240), prioritizing same-state peers. 58 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HOSPITAL FOR BEHAVIORAL MEDICI (Target)MA120$28.7M-12.3%
NEWTON WELLESLEY HOSPITALMA216$624.3M-4.7%
CAPE COD HOSPITALMA239$620.3M-1.3%
BERKSHIRE MEDICAL CENTERMA238$522.9M-12.9%
SAINT VINCENT HOSPITALMA232$404.2M0.2%
CAMBRIDGE HEALTH ALLIANCEMA225$383.9M-50.0%
BETH ISRAEL DEACONESS - PLYMOUMA150$349.1M2.6%
MOUNT AUBURN HOSPITALMA186$337.4M-8.4%
STEWARD ST. ANNES HOSPITALMA175$322.3M12.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$604K+210bp18mo
Cost to Collect4.5%2.5%$575K+200bp12mo
Denial Rate Reduction12.0%6.5%$569K+198bp12mo
A/R Days Reduction5200.0%3800.0%$350K+122bp9mo
Clean Claim Rate88.0%96.0%$18K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$604K
Cost to Collect
$575K
Denial Rate Reduction
$569K
A/R Days Reduction
$350K
Clean Claim Rate
$18K
Total EBITDA Uplift$2.1M
Current EBITDA$-3.5M
+ RCM Uplift+$2.1M
Pro Forma EBITDA$-1.4M
Current Margin-12.3%
Pro Forma Margin-4.9%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.4M$-2.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.4M$-4.2M0.00x-100.0%
Bull Case9.0x11.0x$-4.9M$1.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-4.9M$-304K0.00x-100.0%
Bear Case11.0x10.0x$-6.0M$-11.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.0M$-14.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 58 hospitals with 60-240 beds
  • Same-state prioritization (n=59)
  • Comp margins: P25=-18.4% / P50=-10.7% / P75=0.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.